Medicaid program; time limitation on recordkeeping requirements under the drug rebate program. Final rule
Related Experiment Video
Updated: Aug 20, 2026

Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats
Published on: July 22, 2010
Abstract:
This final rule finalizes 10-year recordkeeping requirements for drug manufacturers under the Medicaid drug rebate program. Manufacturers must retain records for 10 years from the date the manufacturer reports data to us for a rebate period. This final rule also finalizes the requirement that manufacturers must retain records beyond the 10-year period if the records are known by the manufacturer to be the subject of an audit or a government investigation. Furthermore, this final rule responds to public comments on the January 6, 2004 interim final rule with comment period and the proposed rule pertaining to the 10-year recordkeeping requirements, respectively.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Drug Regulation
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug Dosing: Geriatric Patients
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions